Post by Matthias Lutz

On Monday I was invited to the European Commission delegation visit of Ekaterina Zaharieva at Stanford University School of Medicine and had the opportunity to share my perspective as a European researcher at Stanford: The key insight: Stanford University operates less like a traditional university and more like an incubator in itself... and that’s what drives its impact. The lectures I attend here are not fundamentally different from those in Germany. The real difference lies in execution: Students and researchers are consistently pushed to build, test, and implement. They are embedded in strong networks, with opportunities and events at every corner, surrounded by experienced mentors, and supported in turning ideas into real-world solutions. What stands out most is the close link between research and industry. At Stanford, translating research into real-world applications isn’t questioned, it’s expected. In Europe this close interconnection is sometimes viewed more critically, yet it is exactly what enables innovation to reach patients at scale. Europe is also moving in this direction. Through initiatives such as those led by Ekaterina Zaharieva and the European Union, we see growing support for innovation ecosystems and entrepreneurship in science and medicine. The foundation is already there: talent, research, and ambition. What still needs to evolve is the mindset: Towards building, cross-disciplinary collaboration, and a stronger focus on real-world impact.